Abstract OBJECTIVES: Levosimendan (LS) is increasingly used in case of myocardial failure after cardiac surgery. The impact of LS on myocardial mitochondrial functions, such as respiratory chain function (RCF), mitochondrial membrane potential (ΔΨm), Ca 2+ handling, mitochondrial permeability transition pore (mPTP) opening and ATP during ongoing ischaemia/reperfusion (IR) injury, is not well understood. Depending on LS, I/R injury or the combination of both, we analysed myocardial functions in a retrograde Langendorff-model followed by the analysis of subsarcolemmal mitochondrial (SSM) functions.
Impact of levosimendan and ischaemia-reperfusion injury on myocardial subsarcolemmal mitochondrial respiratory chain, mitochondrial membrane potential, Ca 2+ 
INTRODUCTION
Myocardial ischaemia-reperfusion (I/R) injury complicates cardiac surgery and increases mortality, especially in candidates with an impaired ventricular function.
Mitochondrial dysfunction is the driving force for myocardial I/R injury, since mitochondria are responsible for ATP synthesis, cellular Ca 2+ homeostasis and cell death regulation. Oxidative phosphorylation breakdown during ischaemia results in ATP depletion. Subsequent collapse of the cellular Na + /K + -ATPase, followed by cellular Ca 2+ influx, alters intracellular signalling and enzyme phosphorylation. Ca 2+ uptake via the mitochondrial Ca 2+ uniporter is driven by the negative mitochondrial membrane potential (ΔΨm), established by the respiratory chain. Mitochondrial Ca 2+ efflux is provided either by the Na + /Ca 2+ exchanger or by the mitochondrial permeability transition pore (mPTP), with Ca 2+ -binding sites regulating pore activity, resulting in mPTP flickering between opened and closed states [1] . ΔΨm breakdown, cellular Ca 2+ overload and rapid pH increment during reperfusion promote permanent mPTP activation leading to mitochondrial loss and cell death. Hence, stabilization of the RCF, ΔΨm and mitochondrial Ca 2+ homeostasis is pivotal for preserving biochemical processes during myocardial I/R injury.
Levosimendan (LS), a clinically approved Ca 2+ sensitizer, is increasingly applied in case of myocardial failure after cardiac surgery. By binding to the hydrophobic pocket at the aminoterminal region of Troponin C (Trop C) at systolic intracellular Ca 2+ concentrations, LS increases Ca 2+ affinity to Trop C. LS stabilizes the Ca 2+ -induced conformational change of Trop C, resulting in positive inotropic action without changing relaxation time. Additionally, LS is a K þ ATP channel opener, explaining smooth muscle relaxation and vasodilatation [2] . LS-dependent pre-and afterload reduction reduces myocardial wall tension and improves coronary perfusion, thus making mitoK þ ATP channel opening a cardioprotective mechanism. Kopustinskiene et al. [3] examined the mitoK þ ATP channel opening effect of LS on native myocardial mitochondria, suggesting a protective effect of LS in a preconditioning regime of I/R injury. Additionally, Hönisch et al. [4] postulated a reduction of infarct size in a post-conditioning model, suggesting an involvement of mitoK þ ATP channel opening as well. Its potential of improving myocardial function and suppressing I/R injury makes LS an appealing drug in case of ventricular dysfunction after cardiac surgery. Clinically, LS improved survival and end-organ functions of patients suffering from myocardial dysfunction after cardiac surgery. Early application after the onset of low cardiac output is advisable to improve outcome [5] .
While LS-dependent myocardial preconditioning is well analysed, limited research on its impact on mitochondria during ongoing I/R injury has been conducted.
Regarding mitochondrial morphology, two major populations, subsarcolemmal mitochondria (SSM) and interfibrillar myocardial mitochondria, have to be considered. Differences in their morphology and cellular localizations lead to the diversity of biochemical properties and susceptibility to ischaemia. SSM appear to be more susceptible to ischaemic damage and a protective diazoxide-dependent effect is more pronounced in SSM [6] . Therefore, this study elucidates the impact of LS on healthy state SSM after the onset of I/R injury with a focus on respiratory chain function (RCF), ΔΨm stability, Ca 2+ handling, mPTP susceptibility and ATP generation.
MATERIALS AND METHODS

Animals
Animals received humane care in compliance with the Principles of Laboratory Animal Care and the Guide for the Care and Use of Laboratory Animals prepared by the Institute of Laboratory Animal Resources, National Research Council, and published by the National Academy Press, revised in 1996 as well as in compliance with the European Convention on Animal Care. Local authorities approved all animal use. Male Wistar rats (280-320 g) were obtained from Janvier (St Berthevin Cedex, France).
Experimental set-up
All hearts received 5 min of Langendorff pre-perfusion for equilibration before experimentation and were randomly divided into four study groups: single perfusion for 30 min (control), 40 min of normothermic stop-flow ischaemia followed by 30 min of reperfusion (IR) and repetitive set-ups of both with a constant injection of 1.4 µmol LS over a period of 20 min (0.07 µmol/min), starting after 5 min of (re-)perfusion (Levo; Levo-IR). After (re-)perfusion, SSM were isolated and analysed (Fig. 1 ).
Chemicals and buffers
Unless otherwise stated, chemicals were obtained from SigmaAldrich GmbH (Munich, Germany). 
Animal preparation and Langendorff perfusion
Rats were anaesthetized by an isoflurane/oxygen composition (5/95%). After decapitation, hearts were excised. The aorta was cannulated for retrograde perfusion with 10 ml/min iced Custodiol® (histidine, tryptophan, and ketoglutarate) solution for 2 min (Köhler Chemie, Germany) for transfer from the animal laboratory to the Langendorff apparatus (maximum transfer time due to facility restrictions: 3 min). Krebs-Henseleit bicarbonate (KHB) buffer (118 mM NaCl, 4.7 mM KCl, 1.2 mM MgSO 4 , 1.25 mM CaCl 2 , 1.2 mM KH 2 PO 4 , 25 mM NaHCO 3 and 11 mM glucose) gassed with carbogen was used for constant pressure Langendorff perfusion (aortic pressure = 73.6 mmHg). At the beginning of Langendorff perfusion, a balloon was placed in the left ventricle and left ventricular end-diastolic pressure (LVEDP) was adjusted to 18 mmHg. Before being subjected to group-dependent treatment, all hearts received 5 min of preperfusion for equilibration. IR and Levo-IR were subjected to 40 min of normothermic stop-flow ischaemia before 30 min of reperfusion. For stop-flow ischaemia, the intraventricular balloon remained deflated (LVEDP = 0 mmHg) to avoid inhomogeneous myocardial ischaemia patterns. Control and Levo received 30 min of perfusion without ischaemia after equilibration. During (re-)perfusion, Levo and Levo-IR received LS application between 5 and 25 min as described above (Fig. 1) . During (re-)perfusion, left ventricular pressure (LVP) and its derivate (contractility, LVdp/dt max ) were determined by the intraventricular balloon. In this context, the balloon was re-inflated back to the pre-ischaemic LVEDP of 18 mmHg. The LVEDP was maintained at stable values throughout the experiment by constant manual re-adjustments using a Hamilton syringe. After equilibration, eluate was collected at 0 and 30 min during (re-)perfusion and stored at −80°C. Afterwards, hearts were transferred into iced perfusion buffer for isolation of mitochondria. The cardiac apex was excised and stored at −80°C for later analysis.
Cardiac enzyme analysis
Troponin T, CK-MB isoenzyme, myoglobin and heart fatty acidbinding protein (hFABP) were quantified from eluate. Enzymes were determined according to the validated standard procedures of the local department for medical chemistry. Values were expressed as international units per millilitre (U/ml). hFABP was quantified from the eluate and cytosolic fraction of the SSM isolation according to the manufacturer's instructions (HK141 ELISA Kit, Hycult Biotech, Uden, Netherlands).
Isolation of myocardial mitochondria
SSM were isolated according to Palmer et al. [7] using a buffer containing 180 mM KCl, 10 mM EDTA, 0.5% albumin at pH 7.4. Briefly, tissues were dispersed by using the Potter technique followed by differential centrifugation. Washing and storage of the SSM pellet was performed in 225 mM mannitol, 75 mM sucrose and 20 mM Tris, pH 7.4. A bicinchoninic assay determined SSM protein concentrations (BCA Kit, Fisher Scientific, Germany).
Assay of mitochondrial oxygen consumption and analysis of respiratory chain complexes
According to a modified protocol by Zini et al. [8] , a temperaturecontrolled Clarke-type oxygen electrode (Hansatech Instruments Ltd, Norfolk, UK) measured oxygen consumption of SSM in a buffer (300 mM mannitol, 10 mM KH 2 PO 4 , 10 mM KCl and 5 mM MgCl 2 , pH 7.2) at 25°C. release by mPTP opening. In a parallel assay, additional application of 0.5 µM cyclosporine A (CsA) delayed mPTP opening.
Analysis of mitochondrial membrane potential
Mitochondrial permeability transition pore susceptibility testing by Ca 2+ -induced swelling Ca 2+ -induced swelling of energized SSM was determined according to a modified protocol by Simon et al. [10] . One hundred and fifty microgram of SSM was suspended in a 200-µl buffer (250 mM sucrose and 5 mM KH 2 PO 4 , pH 7.2). Complex I was blocked by 3 µM rotenone. The addition of 6 mM succinate energized SSM. Ca 2+ (50 µM) induced swelling, determined by the absorption decline at 520 nm by an Ultrospect 3000 spectrophotometer (GE Healthcare, Munich, Germany). Ca 2+ -induced swelling in a parallel assay was inhibited by 50 mM pyruvate.
Analysis of mitochondrial ATP content and ATP production
For ATP content detection, 2.5 mM pyruvate and malate energized 100 µg SSM. The bioluminescence assay was performed according to the manufacturer's instructions (Molecular Probes, Life Technologies, Darmstadt, Germany). ATP production was quantified in energized SSM (50 µg), incubated with increasing ADP (0.4, 0.5 and 0.6 µM) concentrations. The bioluminescence signal was detected by an Infinite® 200 Pro multimode reader (Tecan, Crailsheim, Germany).
Statistical analysis
Data acquisition was performed using Microsoft Excel. Data analysis was done with Graphpad Prism for Mac OS X, Version 6.0e. Results are expressed as means ± standard deviation (SD), unless otherwise stated. An ANOVA in combination with Bonferroni correction for multiple comparison tests was applied to test for intergroup differences. The analysis of continuous data was performed using a two-way ANOVA with Bonferroni correction for multiple comparison tests. A value of P < 0.05 was considered statistically significant. 
RESULTS
Myocardial function
Myocardial marker enzymes
As determined from eluate, significant differences between I/R injury groups (IR and Levo-IR) and corresponding Control groups (Control and Levo) were evident at 30 min of reperfusion for TropT, CK/MB, myoglobin and hFABP. LS did not impact on the liberation of myocardial marker enzymes. Compared with Controls (1011 ± 924 pg/ml), baseline TropT values did not differ in IR (798 ± 625 pg/ml), Levo (1582 ± 1008 pg/ml) or Levo-IR (1023 ± 392 pg/ml). After 30 min of (re-)perfusion, differences between Control and IR (710 ± 589 vs 2541 ± 1503 pg/ml; P = 0.006) or Levo and Levo-IR (1427 ± 1122 vs 3719 ± 1765 pg/ml; P < 0.0001) achieved significance. Similar results were obtained for CK/MB (P > 0.24) with equal baseline values among Controls (25.4 ± 21.3 U/l), IR (19.0 ± 13.8), Levo (30.8 ± 15.1 U/l) and Levo-IR (29.7 ± 23.0 U/l). After 30 min of (re-)perfusion, significant differences between Control and IR (0.2 ± 0.3 vs 27 ± 27 U/l; P = 0.005) or Levo and Levo-IR (6.0 ± 8.4 vs 33.9 ± 18.4 U/l; P < 0.0007) were evident. Myoglobin and hFABP values were exclusively obtained after 30 min of reperfusion time. Regarding hFABP, significant differences were detected between Levo and Levo-IR (0.72 ± 0.88 vs 2.82 ± 1.21 µg/mg protein; P < 0.002). Myoglobin differed between Controls and IR (12.2 ± 12.2 vs 224.5 ± 128.5 µg/ml; P < 0.0001) and IR and Levo-IR (224.5 ± 128.5 vs 111.1 ± 105.9 µg/ml; P < 0.03).
Analysis of respiratory chain function
Comparing complex I-V (C I-V) of IR with Control (Fig. 3) yielded a decelerated state3-respiration (P = 0.044). LS applications (Levo and Levo-IR) limited state3-respirations compared with corresponding groups, namely control (P < 0.0001) and IR (P = 0.06). In this context, effective C I-V inhibition by the combination of I/R injury and LS in Levo-IR summarized when compared with control (P < 0.0001).
State3-respiration of complex II-V showed similar results. Compared with Control, declines of state3-respiration in IR (P < 0.0001) or Levo were highly significant (P < 0.0001). Complex IV function of Levo compared with Control also showed a limited respiration (P = 0.04). indicates the beginning of data acquisition after pre-perfusion (Control and Levo) or after stop-flow ischaemia (IR and Levo-IR). Regarding IR vs Control (P = 0.04) and Levo-IR vs Levo (P = 0.001), differences were evident. LVdp/dt max (B) revealed differences between IR vs Control (P = 0.004) and Levo-IR vs Levo (P < 0.001). Values are expressed as means ± standard error of the mean. (C) Compared with Control, heart rate differences were significant in IR (P = 0.01) or Levo (P = 0.06). Asterisks indicate statistical significances of the rows (*P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001). LVP sys : left ventricular pressure; LVdp/dt max : Left ventricular contractility.
Mitochondrial membrane potential determination
ΔΨm and its stability in the presence of the uncoupler CCCP were determined from JC1-labelled SSM (Fig. 4) . Regarding globalcurve analysis, significant ΔΨm hypopolarization of SSM subjected to IR (P = 0.04) or Levo (P = 0.02) was evident when compared with Control. Before energizing (a), Control SSM demonstrated highest ΔΨm generation. Compared with Control, differences regarding ΔΨm were observed in Levo (*P = 0.02), IR (**P = 0.05) or Levo-IR (***P = 0.05). In the presence of rotenone/succinate (b → c), controls generated highest ΔΨm with hypopolarization in IR ( 
Mitochondrial Ca
2+ uptake and Ca 2+ liberation Ca 2+ cycling was determined from SSM stained by Ca 2+ green and challenged by 50 µM Ca 2+ (Fig. 5) . According to non-linear 
2+ retention capacity
Mitochondrial Ca 2+ retention capacity (CRC; Fig. 6 ) was determined in the absence or presence of CsA. In the absence of CsA, control SSM resisted 10.5 ± 2.6 Ca 2+ pulses before mPTP opening. Compared with control, IR resulted in an impaired CRC of 6.4 ± 2.1 pulses (P = 0.04). Levo demonstrated a similar limitation to 6.5 ± 2.0 pulses (P = 0.023) and in Levo-IR, CRC was reduced down to 4.9 ± 1.7 (P = 0.0008).
After CsA-induced mPTP blockade, control SSM again showed the highest CRC of 18.5 ± 4.7 pulses. Compared with Control, IR resisted 10.1 ± 2.3 pulses (P < 0.0001), Levo 13.1 ± 4.5 pulses (P < 0.001), and Levo-IR 9.8 ± 3.9 (P < 0.0001).
Mitochondrial membrane transition pore susceptibility towards Ca
2+
In the presence of 50 µM Ca 2+ , mitochondrial membrane transition pore (mPTP) opening caused mitochondrial swelling (Fig. 7) . Compared with Controls, swelling acceleration was observed in IR (P = 0.023) and Levo-IR (P = 0.003).
The application of 0.1 M pyruvate delayed Ca
-induced mPTP opening in all four study groups resulting in vanishing differences between the groups (P = 0.2).
When compared with experiments without pyruvate supplement resulted in delayed swelling in Control (P = 0.003) or Levo-IR (P = 0.002) and IR (P = 0.0007).
Mitochondrial ATP and ATP production capacity ATP content of SSM (Fig. 8) was determined in the absence of ADP. Compared with Control, Levo-IR caused a significant reduction in ATP content (P = 0.04).
ATP production capacity was determined from SSM supplemented with increasing ADP concentrations. Levo resulted in a limited ATP production when compared with control (P = 0.0006). When compared with IR, ATP production was also reduced in Levo-IR (P = 0.006). In case of Levo, these results were accentuated in the presence of 0.5 µM (P = 0.04) and 0.6 µM ADP (P = 0.007). Compared with IR, Levo-IR revealed impaired ATP production at any ADP concentration (P = 0.02-0.0002).
Relative ATP production capacity was computed from absolute ATP production values divided by mean ATP contents determined at baseline in the absence of ADP. Compared with control, relative ATP production capacity was accelerated in IR (P = 0.003), but Levo-IR compared with IR presented an inhibited acceleration of relative ATP production capacity (P = 0.0005). -induced mPTP opening in all groups, resulting in vanishing differences between groups (P = 0.2). When compared with experiments without, pyruvate supplement resulted in delayed swelling in Control (P = 0.003) or Levo-IR (P = 0.002) and IR (P = 0.0007). SSM: subsarcolemmal mitochondria; mPTP: mitochondrial permeability transition pore; CSA: cyclosporine A.
DISCUSSION
LS improves the failing myocardium in case of low cardiac output syndrome after cardiac surgery. It is also believed to protect the myocardium from mitochondrial dysfunction when used for pharmacological preconditioning before inducing I/R injury. MitoK þ ATP channel opening appears to be the underlying mechanism [3, 11] .
In our model of ongoing I/R injury, we applied an increased LVEDP (18 mmHg) to mimic congestive myocardial insufficiency. In analogy to the results of Kolseth obtained from a porcine model of acute ischaemia, LS failed to improve ventricular function [12] . Instead, he described the impact on chronotropy and vasodilatation, resulting in an improved cardiac output at highdose LS application (80 µg/kg). Failure to detect the impact of LS presumably results from limitations of our model: a short perfusion time and the disability to monitor vascular relaxation or improvement of ventricular filling are to be addressed.
During I/R injury, mitochondrial energy supply determines organ recovery. SSM are highly susceptible to ischaemic damage. RCF plays a decisive role for maintaining energy supply with its regulation being linked to ΔΨm, ATP and ROS production. Combining the aforementioned parameters according to Hüttemann et al. [13] , controls resemble SSM in the physiological state, whereas IR SSM represent a hypoactive state, demonstrating decreased RCF, ΔΨm and energy levels. Zhang and Paradies assumed protein and lipid peroxidation being responsible for this RCF dysfunction [14, 15] . IR and Levo-IR cumulatively suppressed complex I-V state3 function (+ADP), supporting the interpretation of two distinct mechanisms: IR results in protein and membrane damage, whereas the mitoK þ ATP opener LS interacts with hydrophobic targets of respiratory chain complexes [16] . Our data indicated complex V inhibition as the major relevant factor, because of state3 (+substrate +ADP) rather than state2 dysfunction (+sub-strate). This finding is supported by previous publications, also suggesting complex V to be responsible for observed complex I-V and II-V inhibitions [17, 18] .
Regarding mitoK þ ATP channel openers, Riess earlier pronounced contradictory effects on mitochondrial functions: complex I and II activities in-dependency from different mitoK þ ATP openers and workgroups varied, as a result of varying mitochondrial energetic states [19, 20] . This explains a disparity between our results and the results of other workgroups [11] .
The respiratory chain complexes I, III and IV generate the ΔΨm as a result of energy transfer through the electron transport chain. Hence, ΔΨm generation depends on an intact RCF [21] . However, the ΔΨm hypopolarization we observed is unlikely a consequence of RCF suppression, since group-dependent impact on state2 function remained insignificant. [23, 24] . In this context, we demonstrated a maximum CRC reduction in Levo-IR, suggesting an early temporary Ca 2+ -induced mPTP opening. Huser and Blatter [25] described brief intermittent mPTP openings as a rescue phenomenon to alleviate Ca 2+ overload in the presence of cellular stress. We observed CRC reduction in Levo or Levo-IR; in review of an unaffected Ca 2+ uptake or Ca 2+ -induced swelling by LS, our data also suggest an early temporary Ca 2+ -induced mPTP opening. In contrast to CRC, Ca 2+ -induced mitochondrial swelling indicated permanent mPTP opening. mPTP opening was promoted by I/R injury but not by LS. Pyruvate supplement inhibited Ca 2+ -induced mPTP opening of SSM presumably due to acidification and complex I activation, increasing ΔΨm. In the presence of pyruvate, group-dependent differences of mPTP responses vanished, also suggesting no adverse effect of LS on mitochondrial Ca 2+ handling. Therefore, our data indicate I/R injury being the relevant factor resulting in permanent mPTP opening and LS did not have relevant impact on mPTP.
ATP synthesis reflects the common final path of RCF and ΔΨm. In the presence of LS, limited ATP production was evident. This Levo resulted in limited ATP productions when compared with control (P = 0.0006). Differences in ATP production between IR and Levo-IR were also significant (P = 0.006). In case of Levo, these results were accentuated in the presence of 0.5 µM (P = 0.04) and 0.6 µM ADP (P = 0.007). Compared with IR, Levo-IR revealed impaired ATP production at any ADP concentration (P = 0.02-0.0002). Asterisks indicate statistical significances of the rows (*P < 0.05, **P < 0.01, ***P < 0.001). SSM: subsarcolemmal mitochondria.
effect allegedly depends on the observed complex IV and V inhibition. Complex IV inhibition together with mitoK þ ATP opening resulted in low ΔΨm, consequently depressing the driving force for ATP synthesis at complex V. A similar effect has been reported earlier for the mitoK þ ATP opener pinacidil, also resulting in delayed mitochondrial ATP synthesis from increased K + flux [24] . The impact of a restricted ATP synthesis on mitochondrial energy supply remains vague. An adverse LS-dependent energy balance during I/R injury is imaginable.
LIMITATIONS
Our study suffers from some limitations. We examined a variety of mitochondrial processes depending on LS, I/R injury or the combination of both. Although we were able to suggest underlying pathways, we did not prove our results in more specific systems of isolated mitochondria in the presence of specific inhibitors or channel openers. The present experimental set-up might also bias results. Future studies will have to focus on the effects of LS on ion currents through the inner mitochondrial membrane using specific inhibitors of e.g. H + and K + channels. Additionally, we performed material demanding analyses. The amount of SSM available from myocardium was less effective than calculated, resulting in varying replicates of the performed tests. Yet, the presented studies are quite robust and provide a reliable overview of LS impact on SSM under the circumstances of ongoing I/R injury.
CONCLUSION
I/R injury induced RCF dysfunction and ΔΨm hypopolarization. LS limited RCF in a specific mitoK þ ATP -dependent manner, possibly ameliorating I/R injury [18] . Succeeding ΔΨm hypopolarization depending on LS was evident. During I/R injury, LS increased Ca 2+ redistribution from SSM due to mPTP flickering. Ca 2+ extrusion might protect mitochondria from Ca 2+ overload during I/R injury. In this context, LS did not promote permanent Ca 2+ -induced mPTP opening.
On the other hand, impaired mitochondrial ATP generation in the presence of LS was observed, presumably due to complex IV and V limitations. The relevance of suppressed ATP synthesis on myocardial recovery is arguable [17] .
